Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY)
CUSIP: 75943R102
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 4,389,099
- Total 13F shares
- 91,778,622
- Share change
- +2,633,983
- Total reported value
- $2,894,965,132
- Put/Call ratio
- 74%
- Price per share
- $31.53
- Number of holders
- 132
- Value change
- +$74,331,777
- Number of buys
- 75
- Number of sells
- 43
Quarterly Holders Quick Answers
What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75943R102:
Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
636%
|
27,904,963
|
$1,021,042,000 | — | 30 Jun 2021 | |
| FMR LLC |
13F
|
Company |
236%
|
10,362,000
|
$379,145,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
103%
|
4,540,330
|
$166,131,000 | — | 30 Jun 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
102%
|
4,487,776
|
$164,208,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
98%
|
4,293,442
|
$157,096,000 | — | 30 Jun 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
77%
|
3,375,058
|
$123,493,000 | — | 30 Jun 2021 | |
| BVF INC/IL |
13F
|
Company |
67%
|
2,938,202
|
$107,509,000 | — | 30 Jun 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
65%
|
2,854,040
|
$104,429,000 | — | 30 Jun 2021 | |
| Bellevue Group AG |
13F
|
Company |
60%
|
2,640,962
|
$96,633,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
51%
|
2,218,160
|
$81,162,000 | — | 30 Jun 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
46%
|
2,018,097
|
$73,842,000 | — | 30 Jun 2021 | |
| Alphabet Inc. |
13F
|
Company |
42%
|
1,826,876
|
$66,845,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
32%
|
1,423,327
|
$52,080,000 | — | 30 Jun 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
29%
|
1,294,132
|
$47,352,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
29%
|
1,268,187
|
$46,403,000 | — | 30 Jun 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
28%
|
1,244,765
|
$45,546,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
27%
|
1,173,482
|
$42,938,000 | — | 30 Jun 2021 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
19%
|
835,538
|
$30,572,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
16%
|
707,895
|
$25,901,000 | — | 30 Jun 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
14%
|
600,000
|
$21,954,000 | — | 30 Jun 2021 | |
| BESSEMER GROUP INC |
13F
|
Company |
13%
|
584,463
|
$21,386,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
13%
|
569,645
|
$20,843,000 | — | 30 Jun 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
13%
|
562,938
|
$20,598,000 | — | 30 Jun 2021 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
13%
|
556,380
|
$20,358,000 | — | 30 Jun 2021 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
12%
|
541,124
|
$19,800,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
12%
|
522,106
|
$19,104,000 | — | 30 Jun 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
10%
|
450,258
|
$16,475,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
9.1%
|
400,000
|
$14,636,000 | — | 30 Jun 2021 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
9.1%
|
400,000
|
$14,636,000 | — | 30 Jun 2021 | |
| First Light Asset Management, LLC |
13F
|
Company |
8.9%
|
390,555
|
$14,290,000 | — | 30 Jun 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
8.5%
|
372,195
|
$13,619,000 | — | 30 Jun 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
8%
|
350,000
|
$12,807,000 | — | 30 Jun 2021 | |
| HARBOURVEST PARTNERS LLC |
13F
|
Company |
6.8%
|
296,402
|
$10,845,000 | — | 30 Jun 2021 | |
| Woodline Partners LP |
13F
|
Company |
6.6%
|
288,557
|
$10,558,000 | — | 30 Jun 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
6%
|
262,241
|
$9,595,398 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
5.3%
|
230,630
|
$8,439,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
5.1%
|
222,970
|
$8,159,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
4.7%
|
207,511
|
$7,593,000 | — | 30 Jun 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
4.5%
|
198,004
|
$7,245,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
4.5%
|
196,738
|
$7,198,000 | — | 30 Jun 2021 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
4.4%
|
192,521
|
$7,044,000 | — | 30 Jun 2021 | |
| Fernwood Investment Management, LLC |
13F
|
Company |
4.2%
|
185,063
|
$6,771,000 | — | 30 Jun 2021 | |
| Grace Capital |
13F
|
Company |
4.2%
|
183,112
|
$6,700,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
3.8%
|
167,373
|
$6,124,000 | — | 30 Jun 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
3.4%
|
149,382
|
$5,466,000 | — | 30 Jun 2021 | |
| Alpine Global Management, LLC |
13F
|
Company |
3.1%
|
135,465
|
$4,957,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.9%
|
127,251
|
$4,656,000 | — | 30 Jun 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
2.9%
|
125,651
|
$4,598,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
2.8%
|
123,226
|
$4,509,000 | — | 30 Jun 2021 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
2.7%
|
120,000
|
$4,391,000 | — | 30 Jun 2021 |
Institutional Holders of Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) as of Q3 2021
As of 30 Sep 2021,
Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,778,622 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Bellevue Group AG, Casdin Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, STATE STREET CORP, BVF INC/IL, and PERCEPTIVE ADVISORS LLC.
This page lists
132
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
124
Q3 2021 holders
132
Holder diff
8
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.